Elixir Capital Intrinsic Value
Elixir Capital (ELIXIR) median intrinsic value is ₹106.67 from 2 valuation models (range ₹47–₹107), vs current price ₹116.75 — -8.6% downside (Trading Near Calculated Value), margin of safety -9.4%. Read ELIXIR dividend history for the complete payout history and dividend yield track record.
ELIXIR Valuation Methods Summary — DCF, Graham Number & P/E
Elixir Capital intrinsic value across 2 models vs current price ₹116.75 — upside/downside and value range per method. For current market price and key ratios, visit Elixir Capital share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹106.67 | ₹96.00 - ₹117.34 | -8.6% | Book Value/Share: ₹133.33, P/B: 0.8x |
| Simple DCF (5Y) | dcf | ₹46.70 | ₹37.36 - ₹56.04 | -60.0% | CF Growth: 5.0%, Discount: 15% |
ELIXIR Intrinsic Value vs Market Price — All Valuation Models
Elixir Capital fair value range ₹47–₹107 vs current market price ₹116.75 across 2 valuation models. Analyse ELIXIR FII DII holdings to track promoter, FII and institutional holdings.
ELIXIR Intrinsic Value Analysis — Undervalued or Overvalued?
Elixir Capital median intrinsic value ₹106.67, current price ₹116.75 — Trading Near Calculated Value by 8.6%, margin of safety -9.4%.
What is the intrinsic value of ELIXIR?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Elixir Capital (ELIXIR) is ₹106.67 (median value). With the current market price of ₹116.75, this represents a -8.6% variance from our estimated fair value.
The valuation range spans from ₹46.70 to ₹106.67, indicating ₹46.70 - ₹106.67.
Is ELIXIR undervalued or overvalued?
Based on our multi-method analysis, Elixir Capital (ELIXIR) appears to be trading near calculated value by approximately 8.6%.
ELIXIR Financial Health — Key Ratios vs Industry Benchmarks
Elixir Capital financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | -35.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 850.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | -0.03x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
ELIXIR Cash Flow Quality — Operating & Free Cash Flow
Elixir Capital operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹-17 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹5 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-2 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |